eribulin mesylate,selinexor
eisai pharmaceutical,astrazeneca,karyopharm,hutchmed
['solid tumor', 'eribulin', 'selinexor', 'breast', 'award', 'karyopharm']
truly honored to work with the legends dr and dr funda meric-bernstam to present our #meritaward winning poster: phase ib study of selinexor and eribulin combination in advanced solid tumors and triple-negative breast cancer #asco22 
Early Phase Clinical Trials Fellow at M.D. Anderson Cancer Center | Combining Precision Oncology & Radiation | Former UTMB Chief Fellow | RT Alumni CMC Vellore